For Business Use Only. Does Not Ship to Residential Addresses. For use inside an Analyzer, Sold Separately.

Thermo Kit EtG Rgt 500mL CJF

https://blockscientific.odoo.com/web/image/product.template/97752/image_1920?unique=0a6a171

Thermo Kit EtG Rgt 500mL CJF

In Stock

3,589.61 3589.61 USD 3,589.61

3,589.61

    This combination does not exist.

     Easily reorder reagents and American-made parts.
     Enjoy the fair price promise.
     Take pressure off your budget (and yourself)

                  

    Product Code: 10015893

    Manufacturer: Thermo Scientific

    Shipping Weight: 2.00lbs (0.91kg)

    Specifications

    Brand: DRI®

    Manufacturer: Ortho Clinical Diagnostics

    Country of Origin: United States

    Application: Reagent

    For Use With: For Clinical Chemistry Analyzers

    Form: Liquid

    Sample Type: Urine Sample

    Storage Requirements: Requires Refrigeration

    Test Name: Ethyl Glucuronide (EtG)

    Test Type: Drugs of Abuse

    Volume: 500 mL

    Intended Use

    The Thermo ScientificTM DRI Ethyl Glucuronide Enzyme Immunoassay is intended for the qualitative and semi-quantitative determination of Ethyl Glucuronide in human urine at cutoffs of 500 ng/mL and 1000 ng/mL.

    Summary and Explanation of the Test

    Ethyl Glucuronide (EtG) is a direct metabolite of ethanol, which is formed by enzymatic conjugation of ethanol with glucuronic acid. Alcohol in urine is normally detected for only a few hours, where as EtG can be detected up to several days even after complete elimination of alcohol from the body. Currently EtG is monitored by GC/MS and LC/MS/MS.

    The DRI® Ethyl Glucuronide Assay is supplied as a liquid ready-to-use homogeneous enzyme immunoassay. The assay uses specifi c antibodies that can detect Ethyl Glucuronide without any significant cross-reactivity to other glucuronide compounds. The assay is based on competition between a drug labeled with glucose-6-phosphate dehydrogenase (G6PDH), and free drug from the urine sample for a fi xed amount of specifi c antibody binding sites. In the absence of free drug from the sample, the specifi c antibody binds the drug labeled with G6PDH and causes a decrease in enzyme activity. This phenomenon creates a direct relationship between the drug concentration in urine and enzyme activity. Active enzyme converts NAD to NADH resulting in an absorbance change that can be measured spectrophotometrically at 340 nm.